Form 4: Director Hedley Acquires Eli Lilly Shares Through Directors' Deferral Plan

Mary Lynne Hedley, a director at Eli Lilly & Co, acquired shares of common stock through the company's Directors' Deferral Plan.

Summary

• On May 19, 2025, Mary Lynne Hedley, a director of Eli Lilly & Co, acquired 13.133 shares of common stock at a price of $755.11 per share.
• The acquisition was made through the Lilly Directors' Deferral Plan, where shares are deferred in lieu of cash compensation and will be settled in shares of common stock following separation from service.
• Following the transaction, Hedley directly owns 1,944.16 shares of Eli Lilly common stock.
• Hedley also indirectly owns 98 shares through a trust, but disclaims beneficial ownership except to the extent of her pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a routine transaction by a company director. The acquisition through the deferral plan is a positive sign, but not significantly impactful.

Positives

• Director's participation in the Directors' Deferral Plan demonstrates confidence in the company's future.

Future Outlook

The acquired shares will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

Form 4 filings are routine disclosures of transactions by company insiders and provide transparency to the market.

Stakeholder Impact

• The transaction increases the director's stake in the company, aligning her interests with those of other shareholders.

Key Dates

Keywords

Eli Lilly, LLY, Director, Hedley, Share Acquisition, Directors' Deferral Plan, Form 4, Beneficial Ownership